The abstract is read at the publisher; the summary is JClub's.
Linezolid shows bactericidal activity against Staphylococcus aureus in Mueller-Hinton Broth, but only bacteriostatic activity in human CSF, with growth slower in hCSF.
- Why it matters: Central nervous system infection models need media that reflect CSF conditions; otherwise, PK/PD conclusions from standard broth may misestimate bacterial growth and required dosing.
- What they did: Time-kill curves over 30 h tested 0, 0.25, 1, and 4× linezolid MIC in MHB, artificial CSF, and human CSF, then a hollow-fiber infection model reproduced CSF PK profiles over 96 h.
- The result: In HFIM, growth was predicted slower in hCSF than MHB; 900 mg q8h was needed for bactericidal effect in MHB, while 600 mg q12h sufficed in hCSF, and artificial CSF showed no growth or treatment impact.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.